SCHEMBL3022909

SCHEMBL3022909

O=[N+]([O-])Cc1ccc(F)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.42
PIK3CA P42336 1/20 0.42
CNR2 P34972 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
THRB P10828 1/20 0.41
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
PARP1 P09874 2/20 0.37
RPA1 P27694 1/20 0.37
ARNT P27540 1/20 0.36
EPAS1 Q99814 1/20 0.36
TSHR P16473 3/20 0.36
MAPK1 P28482 1/20 0.36
HTR2A P28223 1/20 0.36
GRM2 Q14416 1/20 0.36
HIF1A Q16665 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3028532 0.82 DAO (0.41) DAOALDH1A1MAPTHIF1A
SCHEMBL3860830 0.82 HSD17B10 (0.50) TSHR
SCHEMBL3025962 0.78 DAO (0.45) DAOALDH1A1MAPTHDAC3HDAC1
SCHEMBL1281700 0.76 CYP1A2 (0.50) ALDH1A1MAPTTSHRMAPK1CYP1A2
SCHEMBL5650950 0.74 PIK3CA (0.47) DAOPIK3CACNR2ALDH1A1MAPT
SCHEMBL1615449 0.74 TSHR (0.50) ALDH1A1MAPTTSHRMAPK1CYP1A2
SCHEMBL27636854 0.74 MRGPRX4 (0.46) ALDH1A1PARP1
SCHEMBL3026505 0.73 ALDH1A1 (0.52) DAOALDH1A1TSHR
SCHEMBL9322428 0.72 LOXL2 (0.42) ALDH1A1TSHRCYP1A2CYP2C9CYP2C19
SCHEMBL3027815 0.72 MAPT (0.47) ALDH1A1MAPTTSHRMAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067911-B2 Piperidine derivatives HOFFMANN-LA ROCHE INC. (US) 2015-06-30 US disclosed
EP-2391603-B1 AROYLAMINO - AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS HOFFMANN LA ROCHE (CH) 2014-01-08 EP disclosed
US-20130158050-A1 PIPERIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2013-06-20 US disclosed
US-20100197715-A1 PIPERIDINE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158050-A1 PIPERIDINE DERIVATIVES GRIN1, GRIN2A, GRIN2C DAO 2307/4885PIK3CA 2774/4885CNR2 107/4885
US-20100197715-A1 PIPERIDINE DERIVATIVES GRIN1, GRIN2A, GRIN2C DAO 2307/4885PIK3CA 2774/4885CNR2 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.